Articles

• Regulatory compliance: Understanding and harmonisation are the way forward

  2013-05-03

  Regulatory compliance will always be complicated, not least when different markets have different rules.And the new focus on delivering quality via operational excellence is challenging
  

• The risk of not using a risk-based approach

  2013-04-25

  Interview with Clinton Weber, about his experiences with new regulations as Senior Manager Technical Operations at contract manufacturer CMC ICOS Biologics, Seattle.
  

• Unlocking the knowledge

  2013-04-19

  Inteview with Nuala Calnan, PhD Researcher, Dublin Institute of Technology (DIT), based on her experience working within the regulatory cGMP environment and her current research into the practical impacts on the manufacturing processes of the industry.
  

• A satisfactory year

  2013-04-05

  In 2012, NNE Pharmaplan delivered its strongest financial result so far with an increase in turnover of 11% and an operating profit margin of 3.9%.
  

• Project news

  2013-03-01

  We are happy to announce that we have won the European Spallation Source project in Lund, Sweden together with Henning Larsen Architects A/S, COBE ApS and SLA A/S.
  

• GMP and compliance courses 2013

  2012-12-07

  NNE Pharmaplan is proud to present a new series of GMP and compliance training courses in 2013
  

• Risk Analysis and Mitigation Matrix (RAMM) - a risk tool for quality management

  2012-08-29

  This article presents a new type of risk tool: Risk Analysis and Mitigation Matrix (RAMM), which is developed to be incorporated into a modern risk management system and align with latest FDA guidances. It won ISPE's Article of the Year award for 2011/12
  

• Project news

  2012-06-27

  NNE Pharmaplan is proud to announce that we are part of the team which will design Aalborg New University Hospital.
  

• Building on heritage

  2012-06-22

  The pharmaceutical industry is facing many challenges including patent expiry, slashed public healthcare budgets, greater regulatory hurdles and escalating R&D costs.
  

• Job openings worldwide

  2012-06-19

  Right now, we are seeking new colleagues in many of our global offices
  

• Biotech on demand

  2012-04-24

  China’s pioneering biopharmaceutical companies – free from traditional constraints – are reinventing biotech manufacturing
  

• Saving lives, saving money

  2012-04-24

  As the global population grows and life expectancy rises, biopharmaceuticals are in ever greater demand for the treatment of life-threatening and chronic diseases. But this class of medicine often comes with a high price tag.
  

• Read the latest Angle

  2011-12-08

  Angle is our theme-based magazine about global health issues and the pharmaceutical world around us. It is published three times a year. We cover specially selected themes by investigating them from the key angles of society, industry and patient.
  

• Think again...

  2011-11-02

  The time when emerging markets solely acted as the West’s extended production arm is long since gone. Research, ideas and new products increasingly stem from India and China in particular – major countries intent on setting their own agenda.
  

• Practical experience by deployment of MES in the pharmaceutical industry

  2011-10-06

  After years of hesitation the pharmaceutical industry is slowly embracing Manufacturing Execution Systems (MES) as an important mean to gain business benefits.
  

• Winning the MAb race

  2011-10-05

  Next-generation facilities for monoclonal antibody production
  

• Manufacturing systems solution

  2011-09-15

  Manufacturing systems solution - more than manufacturing execution system (MES)
  

• Quality saves lives

  2011-07-01

  Quality assurance of pharmaceuticals is a major public health challenge, particularly in the light of growing cross-border health issues and the international dimensions of trade.
  

• The big misunderstanding

  2011-07-01

  The pharmaceutical industry has not yet started to exploit the full potential of Quality by Design (QbD). The reason: fundamental misunderstandings about the nature of QbD.
  

• SU equipment validation

  2011-05-12

  A systematic and scientific approach for implementation and validation of single-use equipment
  

• Upcoming events

  2011-05-04

  Browse through our events to find out when we will be exhibiting or speaking near you.
  

• Who will make it?

  2011-02-08

  The pharma industry in the next ten years: Who will make it?
  

• We would like your opinion

  2011-02-08

  You are important to us and we would appreciate your help in improving our website. How? Please fill in a very short questionnaire about what you are looking for, what is important to you and what we can do to our website.
  

• Murder by medicine

  2010-11-15

  Counterfeit medicine is a profitable killer. Millions of people die every year and the earnings run into billions of US Dollars.
  

• A new facility concept

  2010-10-07

  From ‘made to order’ to ‘made to configure’. NNE Pharmaplan is investing in preparing modular vaccine facility concepts, designed for vaccine biotypes.
  

• Advanced therapies

  2010-10-07

  Advanced therapies are changing the role of hospitals. Headed by the hospital sector, the evolution of personal therapy systems is occurring at a rapid pace, bringing with it a need for more advanced and flexible facilities.
  

• The ASTM E2500 paradigm

  2010-10-07

  The ASTM E2500 standard presents an alternative to conventional commissioning and qualification practices which, applied effectively, can save money and time while improving quality and increasing focus on patient safety. How much money can you save?
  

• What we do

  2010-09-14

  Focusing on the pharma and biotech industries, NNE Pharmaplan’s mission is to contribute to a healthier world through the services we deliver. Our new offering catalogue "What we do" shows the wealth of consulting and engineering services that we offer.